104 related articles for article (PubMed ID: 31255902)
41. Pulmonary toxicity in paediatric patients with relapsed or refractory Hodgkin lymphoma receiving brentuximab vedotin.
Faulk KE; Sopfe JM; Campbell K; Liptzin DR; Liu AK; Franklin ARK; Cost CR
Br J Haematol; 2018 Oct; 183(2):251-256. PubMed ID: 30198571
[TBL] [Abstract][Full Text] [Related]
42. Nitrite production in mouse 3T3 fibroblasts by bleomycin-stimulated peripheral blood mononuclear cell factors.
Yamamoto T; Katayama I; Nishioka K
Clin Exp Rheumatol; 1999; 17(3):343-6. PubMed ID: 10410269
[TBL] [Abstract][Full Text] [Related]
43. Expression of transforming growth factor-beta type I and type II receptors is altered in rat lungs undergoing bleomycin-induced pulmonary fibrosis.
Zhao Y; Shah DU
Exp Mol Pathol; 2000 Oct; 69(2):67-78. PubMed ID: 11001857
[TBL] [Abstract][Full Text] [Related]
44. Circulating intracellular adhesion molecule-1 concentrations following bronchial provocation in atopic asthma.
Gonokami Y; Konno S; Kurokawa M; Kawazu K; Ueno K; Tomita K; Ike M; Nyui M; Adachi M
Int Arch Allergy Immunol; 1997 Apr; 112(4):386-91. PubMed ID: 9104795
[TBL] [Abstract][Full Text] [Related]
45. Comparison of the predictive value among inflammation-based scoring systems for bleomycin pulmonary toxicity in patients with germ cell tumors.
Maruyama Y; Sadahira T; Araki M; Mitsui Y; Wada K; Edamura K; Kobayashi Y; Watanabe M; Watanabe T; Nasu Y
Int J Urol; 2019 Aug; 26(8):813-819. PubMed ID: 31115106
[TBL] [Abstract][Full Text] [Related]
46. Prognostic impact of bleomycin-induced pneumonitis on the outcome of Hodgkin's lymphoma.
Ngeow J; Tan IB; Kanesvaran R; Tan HC; Tao M; Quek R; Lim ST
Ann Hematol; 2011 Jan; 90(1):67-72. PubMed ID: 20676640
[TBL] [Abstract][Full Text] [Related]
47. High-dose therapy and autologous hematopoietic cell transplantation in children with primary refractory and relapsed Hodgkin's disease: atopy predicts idiopathic diffuse lung injury syndromes.
Frankovich J; Donaldson SS; Lee Y; Wong RM; Amylon M; Verneris MR
Biol Blood Marrow Transplant; 2001; 7(1):49-57. PubMed ID: 11215699
[TBL] [Abstract][Full Text] [Related]
48. Can We Predict Bleomycin Toxicity with PET-CT?
Beyhan Sagmen S; Comert S; Turan Erkek E; Küçüköz Uzun A; Doğan C; Yılmaz G; Kıral N; Fidan A; Yılmaz Haksal Ç; Torun Parmaksız E
Acta Haematol; 2019; 142(3):171-175. PubMed ID: 31454795
[TBL] [Abstract][Full Text] [Related]
49. Protective effect of peptide DR8 on bleomycin-induced pulmonary fibrosis by regulating the TGF-β/MAPK signaling pathway and oxidative stress.
Wang D; Yan Z; Bu L; An C; Deng B; Zhang J; Rao J; Cheng L; Zhang J; Zhang B; Xie J
Toxicol Appl Pharmacol; 2019 Nov; 382():114703. PubMed ID: 31398421
[TBL] [Abstract][Full Text] [Related]
50. Impact of Bleomycin and Vincristine Dose Reductions in Patients With Advanced Hodgkin Lymphoma Treated With BEACOPP: An Analysis of the German Hodgkin Study Group HD12 and HD15 Trials.
Haverkamp H; Böll B; Eichenauer DA; Sasse S; Fuchs M; Borchmann P; Diehl V; Engert A; von Tresckow B
J Clin Oncol; 2015 Aug; 33(22):2430-6. PubMed ID: 26101245
[TBL] [Abstract][Full Text] [Related]
51. Heat shock protein 70 protects against bleomycin-induced pulmonary fibrosis in mice.
Tanaka K; Tanaka Y; Namba T; Azuma A; Mizushima T
Biochem Pharmacol; 2010 Sep; 80(6):920-31. PubMed ID: 20513440
[TBL] [Abstract][Full Text] [Related]
52. Cigarette smoking aggravates bleomycin-induced experimental pulmonary fibrosis.
Zhou LL; Wang M; Liu F; Lu YZ; Song LJ; Xiong L; Xiang F; He XL; Shuai SY; Xin JB; Ye H; Yu F; Ma WL
Toxicol Lett; 2019 Mar; 303():1-8. PubMed ID: 30572104
[TBL] [Abstract][Full Text] [Related]
53. An evaluation of brentuximab vedotin as a treatment option for stage III/IV Hodgkin lymphoma.
Choi Y; Diefenbach CS
Expert Rev Hematol; 2019 Oct; 12(10):801-808. PubMed ID: 31432732
[No Abstract] [Full Text] [Related]
54. Toxicities associated with bleomycin.
Fyfe AJ; McKay P
J R Coll Physicians Edinb; 2010 Sep; 40(3):213-5. PubMed ID: 21127762
[TBL] [Abstract][Full Text] [Related]
55. Neutralization of the CXC chemokine, macrophage inflammatory protein-2, attenuates bleomycin-induced pulmonary fibrosis.
Keane MP; Belperio JA; Moore TA; Moore BB; Arenberg DA; Smith RE; Burdick MD; Kunkel SL; Strieter RM
J Immunol; 1999 May; 162(9):5511-8. PubMed ID: 10228032
[TBL] [Abstract][Full Text] [Related]
56. [Effects of polydatin on bleomycin-induced pulmonary fibrosis in rats].
Zhang Y; Chen L; Liang B
Zhongguo Zhong Yao Za Zhi; 2011 Dec; 36(24):3528-34. PubMed ID: 22368872
[TBL] [Abstract][Full Text] [Related]
57. Mangiferin attenuates bleomycin-induced pulmonary fibrosis in mice through inhibiting TLR4/p65 and TGF-β1/Smad2/3 pathway.
Jia L; Sun P; Gao H; Shen J; Gao Y; Meng C; Fu S; Yao H; Zhang G
J Pharm Pharmacol; 2019 Jun; 71(6):1017-1028. PubMed ID: 30847938
[TBL] [Abstract][Full Text] [Related]
58. Drug-related pulmonary toxicity in non-Hodgkin's lymphoma. Comparative results with three different treatment regimens.
Shapiro CL; Yeap BY; Godleski J; Jochelson MS; Shipp MA; Skarin AT; Canellos GP
Cancer; 1991 Aug; 68(4):699-705. PubMed ID: 1713121
[TBL] [Abstract][Full Text] [Related]
59. Deglycosylated bleomycin has the antitumor activity of bleomycin without pulmonary toxicity.
Burgy O; Wettstein G; Bellaye PS; Decologne N; Racoeur C; Goirand F; Beltramo G; Hernandez JF; Kenani A; Camus P; Bettaieb A; Garrido C; Bonniaud P
Sci Transl Med; 2016 Feb; 8(326):326ra20. PubMed ID: 26888428
[TBL] [Abstract][Full Text] [Related]
60. Vinblastine, bleomycin, and methotrexate chemotherapy plus irradiation for patients with early-stage, favorable Hodgkin lymphoma: the experience of the Gruppo Italiano Studio Linfomi.
Gobbi PG; Broglia C; Merli F; Dell'Olio M; Stelitano C; Iannitto E; Federico M; Bertè R; Luisi D; Molica S; Cavalli C; Dezza L; Ascari E
Cancer; 2003 Dec; 98(11):2393-401. PubMed ID: 14635074
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
